Biodesix Inc Forecast, price target & analysts
Biodesix Inc Target price 2026 - Analyst rating & recommendation
Biodesix Inc Classifications & Recommendation
Biodesix Inc Price Target
| Target Price | $32.64 |
| Price | $28.81 |
| Potential |
13.29%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Biodesix Inc 2027 .
The average Biodesix Inc target price is $32.64.
This is
13.29%
register free of charge
$42.00
45.78%
register free of charge
$27.27
5.35%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend Biodesix Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Biodesix Inc stock has an average upside potential 2027 of
13.29%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 88.50 | 113.78 |
| 24.09% | 28.56% | |
| EBITDA Margin | -25.51% | -7.91% |
| 37.04% | 69.00% | |
| Net Margin | -39.85% | -25.77% |
| 33.79% | 35.34% |
9 Analysts have issued a sales forecast Biodesix Inc 2026 . The average Biodesix Inc sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Biodesix Inc EBITDA forecast 2026. The average Biodesix Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Biodesix Inc Analysts have issued a net profit forecast 2026. The average Biodesix Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.67 | -2.78 |
| 29.46% | 40.47% | |
| P/E | negative | |
| EV/Sales | 2.82 |
9 Analysts have issued a Biodesix Inc forecast for earnings per share. The average Biodesix Inc EPS is
This results in the following potential growth metrics and future valuations:
Current Biodesix Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Roth Capital |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 15 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 05 2026 |
| William Blair |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Roth Capital:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 15 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 05 2026 |
|
Locked
William Blair:
Locked
➜
Locked
|
Feb 27 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
